P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH THE T315I MUTATION: UPDATED EFFICACY AND SAFETY... by T. Hughes, J. E. Cortes, D. Réa, M. J. Mauro, A. Hochhaus, D.-W. Kim, K. Sasaki, F. Lang, M. C. Heinrich, M. Breccia, M. Deininger, Y.-T. Goh, J. J. Janssen, M. Talpaz, V. Gómez García de Soria, P. le Coutre, S. Kapoor, S. Cacciatore, F. Polydoros, N. Agrawal, F.-X. Mahon

Get full text

S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE... by D. Rea, A. Hochhaus, M. J. Mauro, Y. Minami, E. Lomaia, S. Voloshin, A. Turkina, D.-W. Kim, J. F. Apperley, J. E. Cortes, A. Abdo, L. M. Fogliatto, D. D. H Kim, P. le Coutre, S. Saussele, M. Annunziata, T. P. Hughes, N. Chaudhri, L. Chee, V. García-Gutiérrez, K. Sasaki, S. Kapoor, A. Allepuz, S. Quenet, V. Bédoucha, C. Boquimpani

Get full text